Every fortnight, every third week, seasonally: an unstudied practice
A great deal of practice has grown up around intermittent schedules. The randomised evidence for any of them is, as far as the Journal can establish, nil.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 3 of 5 of this archive, newest first.
A great deal of practice has grown up around intermittent schedules. The randomised evidence for any of them is, as far as the Journal can establish, nil.
The result is unremarkable. What the report omits is not.
A proper account of an operation that existed, and of what closing it cost.
The evidence base is thin and the document says so, which is to its credit.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
A tour of the tissues where the receptor is expressed, and what happens in each.
A proper account of an operation that existed, and of what closing it cost.
The document is four pages. Three of them are about dates.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
A pharmacist catches most of these in licensed practice. In this market there is no pharmacist, so the checks have to be structural.
The same receptor population that produces the therapeutic effect produces the commonest adverse one.
The document is four pages. Three of them are about dates.
The observation that closes a facility is rarely the dramatic one.
Follow the resin, not the catalogue.
A reminder that a purity figure is the output of a method, and that methods differ.
The arithmetic of the reference change value, worked for the analytes that matter here.
A withdrawal trial answers a narrower question than it appears to. This piece states which question.
The document is four pages. Three of them are about dates.
A proper account of an operation that existed, and of what closing it cost.
Efficacy was never the question in this appraisal. Duration of treatment was.
Follow the resin, not the catalogue.
Reversed-phase chromatography runs in an organic, acidic mobile phase that dissociates most non-covalent aggregates on the way to the detector.
Cost is the modal reason for discontinuation in every dataset we have seen, and it is absent from the clinical literature.
A proper account of an operation that existed, and of what closing it cost.
The supplier has not disputed the finding. It has not explained the gap either.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The Journal submitted split samples from single lots to three assay services, under names unconnected to this publication, and published each method alongside each result.
What a verification mark would have to carry to be checkable: a date, a lot, a method, a submitter and a link to the report.
The resistance-training and energy-deficit literature supports a higher protein intake. None of it was conducted in people taking an incretin.
Efficacy was never the question in this appraisal. Duration of treatment was.
Reported from the sessions, and from the two hours afterwards.
The document is four pages. Three of them are about dates.
The document is four pages. Three of them are about dates.
Almost every figure in circulation about tolerability comes from six publications. This is what they say.
Efficacy was never the question in this appraisal. Duration of treatment was.
The observation that closes a facility is rarely the dramatic one.
The evidence base is thin and the document says so, which is to its credit.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The panel drawn during a week of vomiting is measuring the vomiting.
An accumulation model, drawn from published parameters, with its assumptions stated.